Effect of Xuefu Zhuyu Capsule on chest pain after thoracoscopic surgery for early non-small cell lung cancer
- Conditions
- SCLC
- Registration Number
- ITMCTR2100005319
- Lead Sponsor
- Peking University People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Patients who underwent thoracoscopic lobectomy, lobectomy, compound lobectomy or total lobectomy with or without mediastinal lymph node resection;
(2) Postoperative pathological diagnosis was primary non-small cell lung cancer stage I, ? a or carcinoma in situ;
(3) There was no chest pain before operation, but within 3 months after operation;
(4) They were 18-85 years old;
(5) Willing to participate in clinical trials, signed informed consent, and can contact follow-up
Only those who meet all the above conditions can be included in the study
(1) Lung secondary malignant tumor patients;
(2) Patients with severe primary diseases such as heart, brain, kidney;
(3) Psychotic patients;
(4) Those who meet the diagnostic criteria of non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, targeted therapy and received traditional Chinese medicine treatment in recent 3 months;
Those who met any of the above criteria could not be included in this study
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effective rate of pain improvement;Quality of life score;Cough score;TCM syndrome integral;
- Secondary Outcome Measures
Name Time Method